Today's Rundown Featured Story | | | Friday, May 29, 2020 One of the European Commission’s stipulations for Takeda’s purchase of Shire was that it divest the biopharma’s inflammatory bowel disease candidate SHP647. |
|
|---|
|
Top Stories Friday, May 29, 2020 Ipsen has named the head of Sanofi’s vaccines division as its CEO. The new hire, David Loew, arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on rare disease drug palovarotene. Friday, May 29, 2020 Leaders from four of the biggest drugmakers in the world spoke about rising to the challenge of defeating the global pandemic as scaled-up trials and a potential approval peek over the horizon. Monday, May 25, 2020 Jazz Pharmaceuticals is applying its proprietary technology to recognize the potential of combination therapy for treating cancer patients and redefining what is possible in the treatment landscape. Friday, May 29, 2020 Radiation, chemotherapy and surgery don’t cut it against glioblastoma, an aggressive type of brain cancer that often recurs with a vengeance. Ziopharm is working on a “remote-controlled” gene therapy to buy these patients more time—and early data show it extended patients’ lives by more than a year. Friday, May 29, 2020 Myovant Sciences revealed last fall that its prostate cancer drug beat the standard of care at lowering patients’ testosterone levels. Now, it's laying out details, including how quickly the drug worked and how low it brought testosterone levels as well as how the drug affected heart problems in the patient group. Friday, May 29, 2020 Allogene released expanded data from a phase 1 trial of its off-the-shelf, CD19-directed CAR-T, ALLO-501, plus its antibody ALLO-647. The response rate wasn't quite as impressive as what the company reported two weeks ago, but the details could generate some excitement among Wall Street analysts. Friday, May 29, 2020 CanSino Biologics' COVID-19 vaccine yields positive phase 1 data. Takeda's Alunbrig wins FDA nod to treat newly diagnosed ALK-positive non-small cell lung cancer. GlaxoSmithKline adds biologics manufacturing capacity through a $231 million deal with Samsung Biologics. And more. Friday, May 29, 2020 Immunomedics' short-lived CEO Semerjian steps down; Rallybio nabs Alexion vet Armstrong; Flagship brings on Couzelis as CIO. Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|---|
|
Resources Sponsored by: Copyright Clearance Center Dive into the history of biomedical classification and how these systems have evolved to address new technology and use cases. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Sponsored by: Frontage Laboratories, Inc. Listen to our brand-new Frontage Laboratories podcast where you’ll take home tips for developing residual host cell proteins ELISA assay for biopharmaceutical products using commercial kits. Wednesday, May 20, 2020 | Time: 10am-3.30pm (BST) Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research. Sponsored by: Optum The immediacy of EHR data availability can be significantly impactful, particularly as the health care system works to address COVID-19. Download this whitepaper to learn more. Sponsored by: Oracle Health Sciences Patient-facing digital technologies are playing an important role in clinical trials for new drugs and medical devices, to the point where conducting virtual trials is becoming mainstream. But terms like remote trials, direct-to-patient trials, hybrid trials, decentralized trials, and more all add to the confusion of what makes a trial "virtual." Sponsored by: Outer Edge Technology Businesses must maintain pre-pandemic levels of productivity with smaller IT budgets. Learn why an effective Cloud Strategy is imperative for success in these unprecedented times. Presented by: Rousselot | May 28, 2020 | 11am ET / 8am PT / 5pm CEST You are invited to join Rousselot Biomedical for an insightful webinar on excipients for vaccine formulation. Highly purified gelatins can help accelerate vaccine development. Sponsored by: Patheon, by Thermo Fisher Scientific Continuous Manufacturing vs. Batch for Oral Solid Dose Sponsored by: Cenduit, LLC Download this case study to read about how Cenduit navigated these challenges, and successfully supports the trial sponsor to execute the umbrella trial with agility. Sponsored by: Patheon, by Thermo Fisher Scientific Download this whitepaper to learn more about the importance of an integrated approach to formulation. Sponsored by: Acorn AI by Medidata, a Dassault Systèmes company Case Study: Oncology-focused pharmaceutical company strengthens product launch by identifying hundreds of high-value physicians with Acorn AI. Sponsored by: Clarify Health Pharma launch teams spend significant resources on data and analytics with limited ROI. Read this case study to learn how a Life Sciences company identified two times more patients best suited for therapy, using Clarify’s deep and longitudinal patient and HCP insights. Sponsored by: Recro Gainesville Wurster processing is a versatile technique for developing and manufacturing multiparticulates for modified release dosage forms. Read this whitepaper to determine whether Wurster processing is the right option for your project. Sponsored by: AMRI In this webinar, the featured speaker will explore the key advances and critical hurdles for translating these emerging molecular biology technologies into real-world applications and commercial processes. Sponsored by: Quotient Sciences Tufts Center for the Study of Drug Development (CSDD) white paper sharing study results that indicate Quotient Sciences’ Translational Pharmaceutics® platform reduces development times by more than 12 months and lowers R&D costs by more than $100 million per approved new drug. Download the whitepaper. Sponsored by: Lonza This whitepaper summarises approaches for modulating antibody effector functions and pharmacokinetics, and provides examples of antibodies in clinical studies. Sponsored by: BBK Worldwide Leverage strategic solutions to respond to immediate challenges to patient and site engagement from COVID-19, and learn to maximize the FDA guidance on the conduct of clinical trials during a pandemic. | 
